Buxton Helmsley Issues Letter to Endo International Plc. Shareholders and Creditors, Relating to Corporate Malfeasance and False Statements of Financials

Rhea-AI Summary

The Buxton Helmsley Group issued an open letter to shareholders of Endo International Plc, addressing serious issues regarding corporate malfeasance and inaccurate financial statements. BHG's letter follows private communications with the Company, highlighting concerns that may impact shareholder trust and investment stability. BHG urges a thorough review of Endo's financial practices and governance as stakeholders assess the implications for their investments in the company.

Positive

• None.

Negative

• Allegations of corporate malfeasance that could undermine shareholder confidence.
• Concerns over false statements regarding financial position may lead to regulatory scrutiny.

NEW YORK--(BUSINESS WIRE)-- The Buxton Helmsley Group, Inc. (together with certain of its affiliates and clients, “BHG” or “we”), the New York City-based investment advisor to clients with financial interests in Endo International Plc. (“Endo” or the “Company”) (NASDAQ: ENDP), today issued an open letter to shareholders and creditors of the Company, relating to corporate malfeasance and false statements of financial position.

The full open letter to the Company’s shareholders and creditors, along with the private letters between BHG and the Company leading up to this open letter, may be found at: http://www.exposingendo.com/

Members of the Endo International Plc. Board of Directors: Mark G. Barberio, Jennifer M. Chao, Blaise Coleman, Shane M. Cooke, Nancy J. Hutson (Ph.D.), Michael Hyatt, William P. Montague, and M. Christine Smith (Ph.D.).

About Buxton Helmsley: The Buxton Helmsley Group, Inc. ("BHG") is a premier financial service, asset management and securities research firm, providing an array of services to a diversified group of individuals, corporations, trusts and other entities. The firm is headquartered in New York City.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220513005050/en/

Media:

Public Relations and Corp. Comm.

The Buxton Helmsley Group, Inc.

+1 (212) 561 - 5540, Option 4

press@buxtonhelmsley.com

Source: The Buxton Helmsley Group, Inc.

FAQ

What did Buxton Helmsley Group say about Endo International?

Buxton Helmsley Group issued an open letter alleging corporate malfeasance and false financial statements by Endo International.

How might the open letter impact Endo International's stock?

The allegations of corporate malfeasance could negatively affect investor confidence and influence Endo International's stock price.

What is the source of the allegations against Endo International?

The allegations arise from an open letter issued by Buxton Helmsley Group, citing corporate malfeasance and inaccuracies in financial reporting.

When was the open letter regarding Endo International issued?

The open letter was issued by Buxton Helmsley Group on May 13, 2022.